Trimmel Gomes, Producer
Wednesday, February 19, 2025
The GLP-1 medication trend has taken the health and wellness world by storm, largely hailed as a game-changer for weight loss.
Now, new research suggested the benefits of the drugs extend beyond shedding pounds. They could also be powerful tools for improving heart health, particularly for individuals at risk of cardiovascular conditions such as heart disease, stroke and heart failure.
Heart disease remains the leading cause of death worldwide, including among Hispanic Americans, prompting experts to seek innovative ways to reverse the trend. GLP-1 receptor agonists, originally developed to manage Type 2 diabetes, now offer promising cardiovascular benefits by addressing multiple risk factors at once.
Dr. Francisco Parrilla, a cardiologist at Orlando Health, described GLP-1 medications as a game-changer in managing both diabetes and heart health.
"These benefits can be achieved through several mechanisms, improving the glycemic and lipid level control through weight reduction, lowering the blood pressure and decreasing the inflammation in the blood vessels," Parrilla outlined. "The control of all of these factors is fundamental to decreasing the development of cholesterol plaques in the arteries."
The potential of GLP-1s to address health disparities is particularly relevant for Hispanic communities, where rates of Type 2 diabetes and cardiovascular disease exceed national averages.
The link between weight loss and heart health underscores the significance of GLP-1 medications.
Gayle Smith, a bariatric dietitian at Orlando Health, said losing excess weight often brings additional health benefits.
"Because as you lose weight, you improve your heart health and other functions in your body as well as having more energy, ability to get out and exercise, eat healthy," Smith emphasized. "All of that goes together."
Despite their benefits, GLP-1 medications remain out of reach for some patients. The high cost can be a significant obstacle, although Parrilla noted more insurance companies are beginning to cover these drugs as evidence of their cardiovascular benefits grows.
"The benefits from the cardiovascular standpoint are amazing, so in the long term, that will continue to improve, I'm pretty sure about that, and the access will be easier in the future for all the patients. "
Parrilla stressed GLP-1s are not a replacement for traditional heart-disease treatments but rather a complement to established therapies such as cholesterol-lowering drugs, blood pressure medications and lifestyle changes. For patients considering the medications, the advice from both Parrilla and Smith is the same: Consult a health care provider to weigh the risks and benefits.
get more stories like this via email

Social Issues
A bipartisan group of lawmakers in Congress is joining advocates for energy assistance across the country to warn a dangerous situation is brewing for…
Environment
Teams of researchers and volunteers will fan out at dawn Friday with their smartphones and binoculars on the Florida Gulf Coast University campus for …
Environment
Environmental groups across Michigan are pushing back after the U.S. Army Corps of Engineers confirmed it will fast-track Enbridge's Line 5 tunnel …
Social Issues
Indiana lawmakers approved a bill Tuesday to eliminate judgeships in eleven mostly rural counties as part of a statewide judicial reallocation…
For Minnesota households planning future college enrollment, there is a good chance tuition will cost more, as public campuses facing tighter budgets …
Environment
By Seth Millstein for Sentient Climate.Broadcast version by Isobel Charle for Washington News Service reporting for the Sentient-Public News Service C…
Environment
Communities in southern and eastern Montana were connected to passenger rail lines running from Chicago to Seattle until 1979. An effort to fund the …
Environment
By Jessica Scott-Reid for Sentient Climate.Broadcast version by Danielle Smith for Keystone State News Connection reporting for the Sentient-Public Ne…